International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 158-248 doi: 10.5281/zenodo.16416919
Original Article
Outcome Of Ercp Intervention In The Management Of Postoperative Biliary Leakage
 ,
 ,
 ,
 ,
 ,
Published
July 19, 2025
Abstract

Background/Aim: Biliary leakage is a well‑known complication of cholecystectomy, which may be associated with considerable morbidity and mortality. The study's objective is to assess the location of the biliary leak and the outcome of endoscopic treatment for biliary leakage that occurs after surgery.

Method: It is an observational cross-sectional prospective study conducted in a tertiary care center, between January, 2021 to March, 2023, in the Department of Gastroenterology, Gauhati Medical College and Hospital, Assam. Out of total 53 patients, 51patients of postoperative biliary leakage underwent endoscopic retrograde cholangiopancreatography (ERCP) with CBD stenting. Patients with biliary strictures were excluded from the study. All the patients were followed up after the procedure to look for clinical improvement (cessation of bile output from drain, absence of symptoms, improvement in liver function tests) which was confirmed after 8 weeks by absence of biliary leak in repeat ERCP followed by removal of CBD stent.

Results: Patients aged between 31 to 40 years constituted the majority of our study cohort, representing 45.10% of the total. The female population demonstrated a higher susceptibility to post-cholecystectomy biliary leakage, accounting for 56.90% of cases. Among the various clinical manifestations, abdominal pain was predominant, noted in 64.7% of patients, closely followed by abdominal distension in 70.6%. The ERCP intervention stood out as an efficacious therapeutic strategy, resolving biliary leakage in an impressive 92.1% of patients. Notably, the most frequent site of leakage was identified as the cystic duct stump, accounting for 31.4% of cases. The study revealed that ERCP within the first week post-cholecystectomy had a slightly higher success rate of 93.3% compared to 90.5% in delayed interventions, although this was not statistically significant (p=0.77). The study underscores that males have a significant 1.68 times higher odds of successful ERCP outcomes, and interventions conducted within 7 days post-cholecystectomy are associated with a substantial increase in success (OR: 0.51) compared to delayed procedures.

Conclusion: Biliary leak is more frequent after laparoscopic than open cholecystectomy. Earlier endoscopic intervention shows significant and higher success rate.

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
1574 Views
137 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved